Recombinant IL-33 prolongs leflunomide-mediated graft survival by reducing IFN-γ and expanding CD4(+)Foxp3(+) T cells in concordant heart transplantation. [electronic resource]
Producer: 20170619Description: 820-9 p. digitalISSN:- 1530-0307
- Animals
- B-Lymphocytes -- drug effects
- Cytokines -- metabolism
- Drug Synergism
- Female
- Forkhead Transcription Factors -- metabolism
- Graft Survival -- drug effects
- Heart Transplantation
- Heterografts
- Immunity, Humoral -- drug effects
- Immunosuppressive Agents -- administration & dosage
- Interferon-gamma -- metabolism
- Interleukin-33 -- administration & dosage
- Isoxazoles -- administration & dosage
- Leflunomide
- Mice
- Mice, Inbred C57BL
- Rats
- Rats, Inbred Lew
- Recombinant Proteins -- administration & dosage
- Spleen -- drug effects
- T-Lymphocytes, Regulatory -- drug effects
- Th1 Cells -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.